In this study, we used lower doses of the TG NPs and KIM-1-TG NPs (0.1 and 0.2 mg/kg) and greatly decreased adenine-induced kidney damage (Figures 6 and 7A). This evidence concerns the gene HAVCR1 and Nephropathy.